26 phenotypes from 3 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Zfxtm1.1Reiz/Y Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+ involves: 129/Sv * 129S6/SvEvTac	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
Zfxtm1.1Reiz/Y Meox2tm1(cre)Sor/Meox2+ involves: 129S4/SvJaeSor * 129S6/SvEvTac	neonatal lethality, complete penetrance	J:149654
Zfxtm1.1Reiz/Y Tg(Mx1-cre)1Cgn/0 involves: 129S6/SvEvTac * C57BL/6 * CBA	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
	decreased lymphocyte cell number	J:149654
	impaired hematopoiesis	J:149654
Zfxtm1.1Reiz/Y Tg(Nes-cre)1Kln/0 involves: 129S6/SvEvTac * C57BL/6 * SJL	normal mortality/aging	J:149654
	normal nervous system phenotype	J:149654
Zfxtm1.1Reiz/Y Tg(Tek-cre)12Flv/0 involves: 129S6/SvEvTac * C3H * C57BL/6	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
	decreased mature B cell number	J:149654
	decreased T cell number	J:149654
Zfxtm1.1Reiz/Zfxtm1.1Reiz Meox2tm1(cre)Sor/Meox2+ involves: 129S4/SvJaeSor * 129S6/SvEvTac	neonatal lethality, complete penetrance	J:149654
Zfxtm1.1Reiz/Zfxtm1.1Reiz Tg(Nes-cre)1Kln/0 involves: 129S6/SvEvTac * C57BL/6 * SJL	normal mortality/aging	J:149654
	normal nervous system phenotype	J:149654
Zfxtm1.2Reiz/Y involves: 129S6/SvEvTac * C57BL/6 * DBA/2	abnormal extraembryonic tissue morphology	J:149654
	decreased hematopoietic stem cell number	J:149654
	embryonic lethality during organogenesis, complete penetrance	J:149654
Zfxtm1.2Reiz/Zfxtm1.2Reiz involves: 129S6/SvEvTac * C57BL/6 * DBA/2	abnormal extraembryonic tissue morphology	J:149654
	decreased hematopoietic stem cell number	J:149654
	embryonic lethality during organogenesis, complete penetrance	J:149654
Zfxtm1Dcp/Y involves: 129S4/SvJae * BALB/c	decreased body weight	J:41131
	decreased embryo size	J:41131
	decreased primordial germ cell number	J:41131
	neonatal lethality, incomplete penetrance	J:41131
	oligozoospermia	J:41131
Zfxtm1Dcp/Zfx+ involves: 129S4/SvJae * BALB/c	decreased germ cell number	J:41131
	decreased oocyte number	J:41131
	neonatal lethality, incomplete penetrance	J:41131
Zfxtm1Dcp/Y involves: 129S4/SvJae * C57BL/6J	neonatal lethality, incomplete penetrance	J:41131
	postnatal lethality, complete penetrance	J:41131
Zfxtm1Dcp/Zfx+ involves: 129S4/SvJae * C57BL/6J	neonatal lethality, incomplete penetrance	J:41131
	postnatal lethality, incomplete penetrance	J:41131
Zfxtm1Dcp/Zfxtm1Dcp involves: 129S4/SvJae * BALB/c	decreased body weight	J:41131
	decreased embryo size	J:41131
	decreased mature ovarian follicle number	J:41131
	decreased oocyte number	J:41131
	decreased primordial germ cell number	J:41131
	neonatal lethality, incomplete penetrance	J:41131
	reduced female fertility	J:41131
Zfxtm1Dcp/Zfxtm1Dcp involves: 129S4/SvJae * C57BL/6J	abnormal embryonic growth/weight/body size	J:41131
	abnormal fertility/fecundity	J:41131
	abnormal postnatal growth/weight/body size	J:41131
	neonatal lethality, incomplete penetrance	J:41131